You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 24, 2024

SELENIOUS ACID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Selenious Acid, and when can generic versions of Selenious Acid launch?

Selenious Acid is a drug marketed by Am Regent and is included in one NDA.

The generic ingredient in SELENIOUS ACID is selenious acid. One supplier is listed for this compound. Additional details are available on the selenious acid profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Selenious Acid

A generic version of SELENIOUS ACID was approved as selenious acid by AM REGENT on April 30th, 2019.

  Sign Up

AI Research Assistant
Sample questions
  • What is the 5 year forecast for SELENIOUS ACID?
  • What are the global sales for SELENIOUS ACID?
  • What is Average Wholesale Price for SELENIOUS ACID?
Summary for SELENIOUS ACID
Drug patent expirations by year for SELENIOUS ACID
Recent Clinical Trials for SELENIOUS ACID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
American Regent, Inc.Phase 4
Shanghai Zhongshan HospitalN/A
Shanghai Changzheng HospitalN/A

See all SELENIOUS ACID clinical trials

US Patents and Regulatory Information for SELENIOUS ACID

SELENIOUS ACID is protected by zero US patents and one FDA Regulatory Exclusivity.

FDA Regulatory Exclusivity protecting SELENIOUS ACID

NEW CHEMICAL ENTITY
Exclusivity Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent SELENIOUS ACID selenious acid SOLUTION;INTRAVENOUS 209379-003 Aug 30, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Am Regent SELENIOUS ACID selenious acid SOLUTION;INTRAVENOUS 209379-002 Jan 25, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Am Regent SELENIOUS ACID selenious acid SOLUTION;INTRAVENOUS 209379-001 Apr 30, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.